Processing

Please wait...

Settings

Settings

1. WO2020002701 - COMPOUNDS FOR USE IN PREVENTING OR TREATING CANCER

Publication Number WO/2020/002701
Publication Date 02.01.2020
International Application No. PCT/EP2019/067557
International Filing Date 01.07.2019
IPC
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
44
Non-condensed pyridines; Hydrogenated derivatives thereof
445
Non-condensed piperidines, e.g. piperocaine
4523
containing further heterocyclic ring systems
4545
containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
44
Non-condensed pyridines; Hydrogenated derivatives thereof
445
Non-condensed piperidines, e.g. piperocaine
4523
containing further heterocyclic ring systems
4525
containing a five-membered ring with oxygen as a ring hetero atom
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
44
Non-condensed pyridines; Hydrogenated derivatives thereof
445
Non-condensed piperidines, e.g. piperocaine
4523
containing further heterocyclic ring systems
4535
containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
44
Non-condensed pyridines; Hydrogenated derivatives thereof
445
Non-condensed piperidines, e.g. piperocaine
4523
containing further heterocyclic ring systems
454
containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
535
having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
5375
1,4-Oxazines, e.g. morpholine
5377
not condensed and containing further heterocyclic rings, e.g. timolol
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45
Medicinal preparations containing active ingredients not provided for in groups A61K31/-A61K41/132
06
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35
Antineoplastic agents
A61K 31/4545 (2006.01)
A61K 31/4525 (2006.01)
A61K 31/4535 (2006.01)
A61K 31/454 (2006.01)
A61K 31/5377 (2006.01)
A61K 45/06 (2006.01)
CPC
A61K 31/4525
A61K 31/4535
A61K 31/454
A61K 31/4545
A61K 31/5377
A61K 45/06
Applicants
  • FUNDACIÓ HOSPITAL UNIVERSITARI VALL D'HEBRON- INSTITUT DE RECERCA [ES/ES]; Pg. de la Vall d'Hebron, 119-129 08035 BARCELONA, ES
  • INSTITUT UNIV. DE CIÈNCIA I TECNOLOGIA, S. A. [ES/ES]; C. Álvarez de Castro, 63 08100 MOLLET DEL VALLES, ES
Inventors
  • ROMA CASTANYER, Josep; ES
  • PASCUAL GILABERT, Marta; ES
  • SÁNCHEZ DE TOLEDO CODINA, José; ES
  • GALLEGO MELCÓN, Soledad; ES
  • ZARZOSA MARTÍNEZ, Patricia; ES
  • ALONSO FERNÁNDEZ, Javier; ES
  • PÉREZ OZCÁRIZ, Sergio; ES
  • LÓPEZ GÓMEZ, Cristina; ES
  • CASTELLS BOLIART, Josep; ES
Agents
  • PONTI & PARTNERS, S.L.P.; C. Consell de Cent, 322 08007 BARCELONA, ES
Priority Data
18382485.329.06.2018EP
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) COMPOUNDS FOR USE IN PREVENTING OR TREATING CANCER
(FR) COMPOSÉS DESTINÉS À ÊTRE UTILISÉS DANS LA PRÉVENTION OU LE TRAITEMENT DU CANCER
Abstract
(EN)
The present invention relates to compounds of formula (I) for use in preventing and/or treating cancer.
(FR)
La présente invention concerne des composés de formule (I) destinés à être utilisés dans la prévention et/ou le traitement du cancer.
Latest bibliographic data on file with the International Bureau